Integra LifeSciences Holdings CorporationIARTNASDAQ

Revenue (LTM)

$1.6B

+1.5% YoY

Net Income (LTM)

$-516M

-7337.7% YoY

Free Cash Flow

$-31M

Revenue CAGR (5Y)

+3.6%

Marginsdeclining

FCFTurned negative

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1,542	1,558↑1.0%	1,542↓1.0%	1,611↑4.5%	1,635↑1.5%
Gross Profit	945	970↑2.7%	885↓8.8%	882↓0.3%	845↓4.2%
Operating Income	197	239↑21.1%	112↓53.3%	28↓74.5%	68↑140.5%
Net Income	169	181↑6.8%	68↓62.5%	-7↓110.3%	-516↓7337.7%
EBITDA	366	385↑5.0%	256↓33.4%	193↓24.5%	-326↓268.8%
EPS Diluted	1.98	2.16↑9.1%	0.84↓61.1%	-0.09↓110.7%	-6.73↓7361.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	513	457↓11.1%	276↓39.5%	246↓10.9%	235↓4.6%
Total Current Assets	1,154	1,161↑0.7%	1,058↓8.9%	1,082↑2.2%	1,160↑7.2%
Total Assets	3,782	3,890↑2.8%	3,782↓2.8%	4,037↑6.8%	3,602↓10.8%
Total Current Liabilities	340	321↓5.6%	307↓4.3%	922↑200.4%	456↓50.6%
Total Liabilities	2,098	2,085↓0.6%	2,194↑5.2%	2,492↑13.6%	2,559↑2.7%
Total Equity	1,685	1,804↑7.1%	1,588↓12.0%	1,545↓2.7%	1,043↓32.5%
Total Debt	1,666	1,630↓2.2%	1,682↑3.2%	1,985↑18.0%	2,033↑2.4%
Net Debt	1,153	1,173↑1.8%	1,405↑19.8%	1,738↑23.7%	1,798↑3.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	312	264↓15.4%	140↓47.1%	129↓7.6%	50↓61.1%
Capital Expenditure	-48	-47↑2.1%	-67↓42.0%	-104↓56.2%	-81↑22.0%
Free Cash Flow	264	217↓17.8%	73↓66.4%	25↓65.8%	-31↓224.4%
Stock-Based Comp	36	28↓23.4%	20↓27.3%	24↑21.0%	0
Net Change in Cash	43	-57↓231.2%	-180↓217.4%	-30↑83.3%	-11↑62.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance